LENZ Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of LENZ Therapeutics generated cash of -$90,007,000, which is less than the previous year. Cash used in financing activities reached the amount of $190,000 last year. Net change in cash is therefore $138,131,000.
Cash Flow
| 2019 | -19K | 0 | 0 |
|---|---|---|---|
| 2020 | -8.72M | -1.54M | 30.07M |
| 2021 | -52.85M | -5.74M | 417.46M |
| 2022 | -87.98M | -241.86M | 597K |
| 2023 | -90.00M | 226.34M | 190K |
LENZ Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 47.73M | 376.97M | 19.81M | 6K | 25K |
Operating activities | |||||
Net income | -124.65M | -101.05M | -70.76M | -68.37M | -109K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.40M | 8.34M | 734K | 121K | 0 |
Stock-based compensation expense | 0 | 721K | 196K | 0 | 0 |
| Deferred income tax benefit | 0 | 721K | 196K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -2.35M | 194K | 1.82M | 594K | -12K |
Cash generated by operating activities | -90.00M | -87.98M | -52.85M | -8.72M | -19K |
Investing activities | |||||
Purchases Of Investments | -28.12M | -405.51M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -10.85M | -6.59M | -5.74M | -1.54M | 0 |
Acquisitions Net | 1.90M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 226.34M | -241.86M | -5.74M | -1.54M | 0 |
Financing activities | |||||
Common Stock Issued | 257K | 0 | 417.16M | 30.07M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -67K | -79K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 190K | 597K | 417.46M | 30.07M | 0 |
Net Change In Cash | 138.13M | -329.24M | 357.15M | 19.81M | -19K |
Cash at end of period | 185.86M | 47.73M | 376.97M | 19.81M | 6K |